Suchergebnisse - "Keating, Gillian M"

PubPharm (1.150)

1

Correction to: Afatinib in advanced NSCLC: a profile of its use

enthalten in: Drugs & therapy perspectives | 2018

von Deeks, E. | Keating, G.

2

Afatinib in advanced NSCLC: a profile of its use

enthalten in: Drugs & therapy perspectives | 2018

von Deeks, E. | Keating, G.

3

Correction to: Afatinib in advanced NSCLC: a profile of its use

enthalten in: Drugs & therapy perspectives | 2018

von Deeks, E. | Keating, G.

4

Afatinib in advanced NSCLC: a profile of its use

enthalten in: Drugs & therapy perspectives | 2018

von Deeks, E. | Keating, G.

5

Afatinib in advanced NSCLC : a profile of its use

enthalten in: Drugs & therapy perspectives : for rational drug selection and use | 2018

von Deeks, E. | Keating, G.

ErratumIn: Drugs Ther Perspect. 2018;34(4):196. - PMID 31329734

6

Correction to : Afatinib in advanced NSCLC: a profile of its use

enthalten in: Drugs & therapy perspectives : for rational drug selection and use | 2018

von Deeks, E. | Keating, G.

ErratumFor: Drugs Ther Perspect. 2018;34(3):89-98. - PMID 29540977

7

Ticagrelor : A Review in Long Term Secondary Prevention of Cardiovascular Events

enthalten in: Drugs | 2017

von Al-Salama, Z. | Keating, G. | Keam, S.

8

Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events

enthalten in: Drugs | 2017

von Al-Salama, Z. | Keating, G. | Keam, S.

9

Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events

enthalten in: Drugs | 2017

von Al-Salama, Z. | Keating, G. | Keam, S.

10

Apremilast in psoriasis: a profile of its use

enthalten in: Drugs & therapy perspectives | 2017

von Deeks, E. | Lyseng-Williamson, K. | Keating, G.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[115]